Processes for the preparation of (3S,4R)-3-ethyl-4-(3H-imidazo[1,2-a]pyrrolo[2,3-e]-pyrazin-8-yl)-N-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide and solid state forms thereof
PROCESSES FOR THE PREPARATION OF (3S,4R)-3-ETHYL-4 (3H-IMIDAZO[1,2-a]PYRROLO[2,3-e]-PYRAZIN-8-YL)-N-(2,2,2 TRIFLUOROETHYL)PYRROLIDINE-1-CARBOXAMIDE AND SOLID STATE FORMS THEREOF The present disclosure relates to processes for preparing (3S,4R)-3-ethyl-4-(3H-imidazo[1,2 a]pyrrolo[2,3-e]pyrazin-8-yl)-N-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide, solid state forms thereof, and corresponding pharmaceutical compositions, methods of treatment (including treatment of rheumatoid arthritis), kits, methods of synthesis, and products-by process..
| Medienart: |
|
|---|
Patent| Erscheinungsjahr: |
2023 |
|---|---|
| Erschienen: |
2023 |
| Enthalten in: |
Europäisches Patentamt - (2023) vom: 02. Nov. Zur Gesamtaufnahme - year:2023 |
|---|
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
ALLIAN AYMAN D [VerfasserIn] |
|---|
| Links: |
Volltext [kostenfrei] |
|---|
| Themen: |
Sonstige Themen: |
|---|
| Anmerkungen: |
Source: www.epo.org (no modifications made), First posted: 2023-11-02, Last update posted on www.tib.eu: 2024-03-04, Last updated: 2024-03-08 |
|---|
| Patentnummer: |
AU2021236570 |
|---|
| Förderinstitution / Projekttitel: |
|
|---|
| PPN (Katalog-ID): |
EPA015929469 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | EPA015929469 | ||
| 003 | DE-627 | ||
| 005 | 20240308100829.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 230216s2023 xx |||||o 00| ||eng c | ||
| 035 | |a (DE-627)EPA015929469 | ||
| 035 | |a (EPA)AU2021236570 | ||
| 035 | |a (EPA)57209916 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 0 | |a ALLIAN AYMAN D |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Processes for the preparation of (3S,4R)-3-ethyl-4-(3H-imidazo[1,2-a]pyrrolo[2,3-e]-pyrazin-8-yl)-N-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide and solid state forms thereof |
| 264 | 1 | |c 2023 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Source: www.epo.org (no modifications made), First posted: 2023-11-02, Last update posted on www.tib.eu: 2024-03-04, Last updated: 2024-03-08 | ||
| 520 | |a PROCESSES FOR THE PREPARATION OF (3S,4R)-3-ETHYL-4 (3H-IMIDAZO[1,2-a]PYRROLO[2,3-e]-PYRAZIN-8-YL)-N-(2,2,2 TRIFLUOROETHYL)PYRROLIDINE-1-CARBOXAMIDE AND SOLID STATE FORMS THEREOF The present disclosure relates to processes for preparing (3S,4R)-3-ethyl-4-(3H-imidazo[1,2 a]pyrrolo[2,3-e]pyrazin-8-yl)-N-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide, solid state forms thereof, and corresponding pharmaceutical compositions, methods of treatment (including treatment of rheumatoid arthritis), kits, methods of synthesis, and products-by process. | ||
| 650 | 4 | |a C07D: Heterocyclic compounds (macromolecular compounds c08) | |
| 650 | 4 | |a A61P: Specific therapeutic activity of chemical compounds or medicinal preparations | |
| 650 | 4 | |a che | |
| 650 | 4 | |a 615 | |
| 700 | 0 | |a JAYANTH JAYANTHY |4 aut | |
| 700 | 0 | |a MOHAMED MOHAMED-ESLAM F |4 aut | |
| 700 | 0 | |a MULHERN MATHEW M |4 aut | |
| 700 | 0 | |a NORDSTROM FREDRIK LARS |4 aut | |
| 700 | 0 | |a OTHMAN AHMED A |4 aut | |
| 700 | 0 | |a ROZEMA MICHAEL J |4 aut | |
| 700 | 0 | |a BHAGAVATULA LAKSHMI |4 aut | |
| 700 | 0 | |a MARROUM PATRICK J |4 aut | |
| 700 | 0 | |a MAYER PETER T |4 aut | |
| 700 | 0 | |a SHEIKH AHMAD Y |4 aut | |
| 700 | 0 | |a BORCHARDT THOMAS B |4 aut | |
| 700 | 0 | |a KLÜNDER BEN |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Europäisches Patentamt |g (2023) vom: 02. Nov. |
| 773 | 1 | 8 | |g year:2023 |g day:02 |g month:11 |
| 856 | 4 | 0 | |u https://worldwide.espacenet.com/patent/search/family/57209916/publication/AU2021236570A1?q=AU2021236570 |z kostenfrei |3 Volltext |
| 912 | |a GBV_EPA | ||
| 951 | |a AR | ||
| 952 | |j 2023 |b 02 |c 11 | ||